Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jetpack Bio is a biotechnology company developing next-generation cell therapies designed to treat solid tumors. The company's core technology involves "Jetpacks," which are specialized payloads tethered to the surface of CAR-T cells to provide localized support, such as cytokines, within the tumor microenvironment. This localized delivery mechanism is intended to enhance the potency and persistence of the cells while avoiding the systemic toxicity often associated with high-dose cytokine administration. Founded by pioneers in synthetic biology from UCSF, Jetpack Bio aims to transform the landscape of immunotherapy for hard-to-treat cancers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jetpack.